- Ovarian Cyst
- Gynecologic Oncology
- Ovarian Cancer
- OBGYN
- Minimally Invasive Gynecologic Surgery (MIGS)
- Ultrasound
- Ovarian Cystectomy
It is 4:50 on a Friday, and an ultrasound report lands in your inbox: six centimeter complex right ovarian mass, neoplasm cannot be excluded. What happens next? On this episode of BackTable Women’s Health, Dr. Mona Guo and Dr. Marcia Ciccone team up to discuss how general obstetrician gynecologists should evaluate, follow, and operate on adnexal masses and when to refer to gynecologic oncology. They walk through reading the imaging yourself, understanding what “complex” means on a report, ultrasound features and O-RADS, tumor marker selection, and when an MRI adds value beyond ultrasound.
Timestamps
Resources
- ACOG Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. Obstet Gynecol. 2016
- Andreotti RF, et al. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020
- ACR Ovarian-Adnexal Reporting and Data System (O-RADS)
- Modesitt SC, et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol. 2003
- Im SS, et al. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol. 2005
- Society of Gynecologic Oncology
- Moore RG, et al. Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass. Gynecol Oncol. 2015
- Widschwendter M, Salhia B, et al. OvaPrint, A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer. Clin Cancer Res. 2023
- Dr. Bodour Salhia, Keck School of Medicine of USC
- Dr. Mona Guo, Keck Medicine of USC
- Dr. Mona Guo, BackTable contributor page
- Dr. Marcia Ciccone, Keck Medicine of USC
- Dr. Marcia Ciccone, BackTable contributor page
More about this episode
The conversation separates true emergencies like torsion, hemorrhage, and abscess from imaging findings that require faster evaluation, then breaks down the tumor marker panel, including the limits of CA 125, the value of hormonal and GI markers, and how thresholds shift by age and presentation. They review evidence supporting surveillance of simple cysts under ten centimeters, surgical choices between cystectomy and oophorectomy, and the consent and extraction plans that prevent upstaging from a cyst rupture. The episode closes with practical pearls for preventing spill, managing tubo-ovarian abscess, and the value of a quick call to a colleague when the next step is unclear.


